{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:35:26Z","timestamp":1791275726928,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005413","name":"Universit\u00e9 Paris Descartes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005413","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/jid.2015.174","type":"journal-article","created":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T13:55:33Z","timestamp":1430747733000},"page":"2385-2393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Inhibition of EGFR Tyrosine Kinase by Erlotinib Prevents Sclerodermatous Graft-Versus-Host Disease in a Mouse Model"],"prefix":"10.1016","volume":"135","author":[{"given":"Florence","family":"Morin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Kavian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioleta","family":"Marut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Ch\u00e9reau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Cerles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Weill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Nicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Batteux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2015.174_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0093-7754(03)70011-6","article-title":"Preclinical studies with Erlotinib (Tarceva)","volume":"30","author":"Akita","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1038\/jid.2015.174_bb0015","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.moh.0000245689.47333.ff","article-title":"Chronic graft versus host disease","volume":"13","author":"Baird","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"10.1038\/jid.2015.174_bb0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood-2013-07-514372","article-title":"Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease","volume":"123","author":"Bruggen","year":"2014","journal-title":"Blood"},{"key":"10.1038\/jid.2015.174_bb0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbmt.2007.12.002","article-title":"Murine models of chronic graft-versus-host disease: insights and unresolved issues","volume":"14","author":"Chu","year":"2008","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"10.1038\/jid.2015.174_bb0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cytogfr.2013.03.001","article-title":"A myriad of functions and complex regulation of the CCR7\/CCL19\/CCL21 chemokine axis in the adaptive immune system","volume":"24","author":"Comerford","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1038\/jid.2015.174_bb0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2172-5-7","article-title":"Up-regulation of the chemokine CCL21 in the skin of subjects exposed to irritants","volume":"5","author":"Eberhard","year":"2004","journal-title":"BMC Immunol"},{"key":"10.1038\/jid.2015.174_bb0040","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"10.1038\/jid.2015.174_bb0045","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"10.1038\/jid.2015.174_bb0050","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.26898","article-title":"Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma","volume":"59","author":"Fuchs","year":"2014","journal-title":"Hepatol Baltim Md"},{"key":"10.1038\/jid.2015.174_bb0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000365946","article-title":"Comparison of CD163+ CD206+ M2 macrophages in the lesional skin of bullous pemphigoid and pemphigus vulgaris: the possible pathogenesis of bullous pemphigoid","volume":"229","author":"Furudate","year":"2014","journal-title":"Dermatology"},{"key":"10.1038\/jid.2015.174_bb0060","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jdermsci.2009.08.001","article-title":"Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways","volume":"56","author":"Grange","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2015.174_bb0065","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jaci.2014.10.013","article-title":"Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis","volume":"134","author":"Hamilton","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/jid.2015.174_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0008-8749(83)90001-1","article-title":"Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems","volume":"77","author":"Jaffee","year":"1983","journal-title":"Cell Immunol"},{"key":"10.1038\/jid.2015.174_bb0075","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1158\/1078-0432.CCR-05-0790","article-title":"Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen","volume":"11","author":"Johnson","year":"2005","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1038\/jid.2015.174_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1532\/IJH97.04015","article-title":"The pathophysiology of chronic graft-versus-host disease","volume":"79","author":"Kansu","year":"2004","journal-title":"Int J Hematol"},{"key":"10.1038\/jid.2015.174_bb0085","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1002\/art.27626","article-title":"Targeting ADAM-17\/notch signaling abrogates the development of systemic sclerosis in a murine model","volume":"62","author":"Kavian","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1038\/jid.2015.174_bb0090","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.4049\/jimmunol.1103538","article-title":"Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease","volume":"188","author":"Kavian","year":"2012","journal-title":"J Immunol"},{"key":"10.1038\/jid.2015.174_bb0095","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.bmt.1700718","article-title":"Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation","volume":"19","author":"Korholz","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1038\/jid.2015.174_bb0100","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1084\/jem.148.6.1687","article-title":"Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow","volume":"148","author":"Korngold","year":"1978","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2015.174_bb0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12967-014-0265-3","article-title":"Tumor-derived TGF-\u03b2 and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor","volume":"12","author":"Kumai","year":"2014","journal-title":"J Transl Med"},{"key":"10.1038\/jid.2015.174_bb0110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V100.2.406","article-title":"Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse","volume":"100","author":"Lee","year":"2002","journal-title":"Blood"},{"key":"10.1038\/jid.2015.174_bb0115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/bmt.2012.76","article-title":"Chronic GVHD: Where are we? Where do we want to be? Will immunomodulatory drugs help?","volume":"48","author":"Linhares","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1038\/jid.2015.174_bb0120","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.taap.2010.12.011","article-title":"Erlotinib inhibits T-cell-mediated immune response via down-regulation of the c-Raf\/ERK cascade and Akt signaling pathway","volume":"251","author":"Luo","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1038\/jid.2015.174_bb0125","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/art.37873","article-title":"Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade","volume":"65","author":"Marut","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1038\/jid.2015.174_bb0130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.510310314","article-title":"Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice","volume":"31","author":"Nagler","year":"2000","journal-title":"Hepatology"},{"key":"10.1038\/jid.2015.174_bb0135","first-page":"1","article-title":"Chronic graft-versus-host disease: disease biology and novel therapeutic strategies","volume":"67","author":"Nishimori","year":"2013","journal-title":"Acta Med Okayama"},{"key":"10.1038\/jid.2015.174_bb0140","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/sj.jid.5701184","article-title":"The epidermal growth factor receptor system in skin repair and inflammation","volume":"128","author":"Pastore","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2015.174_bb0145","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1684\/bdc.2011.1472","article-title":"[Tyrosine kinase inhibitors]","volume":"98","author":"Robert","year":"2011","journal-title":"Bull Cancer (Paris)"},{"key":"10.1038\/jid.2015.174_bb0150","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/art.20160","article-title":"A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease","volume":"50","author":"Ruzek","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1038\/jid.2015.174_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jdermsci.2006.06.002","article-title":"Thymus and activation regulated chemokine (TARC)\/CCL17 and skin diseases","volume":"43","author":"Saeki","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2015.174_bb0160","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/jcp.21635","article-title":"The epidermal growth factor receptor ligands at a glance","volume":"218","author":"Schneider","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1038\/jid.2015.174_bb0165","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","article-title":"Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse","volume":"182","author":"Servettaz","year":"2009","journal-title":"J Immunol"},{"key":"10.1038\/jid.2015.174_bb0170","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/jid.2015.174_bb0175","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood-2014-01-514752","article-title":"Current issues in chronic graft-versus-host disease","volume":"124","author":"Soci\u00e9","year":"2014","journal-title":"Blood"},{"key":"10.1038\/jid.2015.174_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.med.54.101601.152339","article-title":"Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant","volume":"54","author":"Vogelsang","year":"2003","journal-title":"Annu Rev Med"},{"key":"10.1038\/jid.2015.174_bb0185","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.bbmt.2010.06.015","article-title":"Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD","volume":"16","author":"Wolff","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1038\/jid.2015.174_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbmt.2010.05.011","article-title":"Consensus Conference on Clinical Practice in Chronic GVHD: second-line treatment of chronic graft-versus-host disease","volume":"17","author":"Wolff","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1038\/jid.2015.174_bb0195","doi-asserted-by":"crossref","first-page":"13209","DOI":"10.1074\/jbc.M509771200","article-title":"A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation","volume":"281","author":"Yahata","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2015.174_bb0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1346-8138.2009.00764.x","article-title":"Animal model of systemic sclerosis","volume":"37","author":"Yamamoto","year":"2010","journal-title":"J Dermatol"},{"key":"10.1038\/jid.2015.174_bb0205","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.109.136531","article-title":"Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3","volume":"54","author":"Yang","year":"2009","journal-title":"Hypertension"},{"key":"10.1038\/jid.2015.174_bb0210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.jid.5700517","article-title":"Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma","volume":"127","author":"Zhou","year":"2007","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15418020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15418020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T22:10:25Z","timestamp":1743977425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15418020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0022202X15418020"],"URL":"https:\/\/doi.org\/10.1038\/jid.2015.174","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of EGFR Tyrosine Kinase by Erlotinib Prevents Sclerodermatous Graft-Versus-Host Disease in a Mouse Model","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2015.174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}